Imperial Innovations and the University of Oxford join a group of corporates and venture firms backing the medical diagnostic company.
Imperial Innovations and the University of Oxford join US-based materials company the Dow Chemical Company and Kaiser Permanente Ventures, the corporate venturing unit of US-based healthcare group Kaiser Permanente, in a syndicate investing $28m in Oxford Immunotec, a medical diagnostic company .
The round was led by Imperial Innovations and Invesco Perpetual and also backed by venture firms Clarus, New Leaf, DFJ Esprit, Wellington, SPARK Ventures and NTEC. Oxford Immunotec has now completed five institutional funding rounds totaling approximately…
